Around 1,097 patients have filed a NuvaRing lawsuit so far alleging blood clots, with the cases consolidated to a special federal court in Missouri.
Denver, CO (PRWEB) March 26, 2013
DrugRisks’ birth control resource center is announcing updated news on the site for women using the vaginal ring contraceptive NuvaRing. A federal judge recently postponed the start of more than 1,000 lawsuits by women alleging blood clot injuries from the device.
DrugRisks was created to improve the safety of those using popular prescription devices like NuvaRing by providing the latest warnings, recalls, studies and legal news. Visitors can determine if others are experiencing similar side effects and decide if they need legal advice.
Health experts have warned that contraceptive rings like NuvaRing may have higher risks of blood clots than traditional birth control pills. Last year, the New England Journal of Medicine published a study finding vaginal rings could relate to a 2.5 to 3-fold increased risk of blood clots*.
DrugRisks also contains information showing that FDA has received over 5,300 adverse reports for women using NuvaRing devices.** Most common among the side effects were 1,177 cases of pulmonary embolism and 1,155 reports of thrombosis or deep vein thrombosis. In more than 30% of cases, patients required hospitalization, while 3% ended in death**.
Around 1,097 patients have filed a NuvaRing lawsuit so far alleging blood clots, with the cases consolidated to a special federal court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri.
This month, DrugRisks learned that U.S. District Judge Rodney Sippel, who will preside over the federal cases, issued an order delaying the start of the first NuvaRing trial until October 21, 2013***.
Fortunately, many NuvaRing patients now have time to learn about their legal options.
Anyone who suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact the DrugRisks Center or speak with a lawyer about their legal rights as soon as possible.
Due to the specialized nature of federal MDL drug injury cases, DrugRisks cautions that patients should seek a lawyer with experience in this litigation, and only recommends lawyers and law firms who have already handled NuvaRing lawsuits.
Visit http://www.DrugRisks.com today for more information on the research, side effects and litigation news related to NuvaRing, or to speak with a lawyer.